Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride

References

• American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders4th editionWashington, DCAmerican Psychiatric Association2000
   Google Scholar
• MossSBNairRVallarinoAWangSAttention deficit/hyperactivity disorder in adultsPrim Care200734344547317868755
   PubMed Web of Science ®Google Scholar
• FaraoneSVSpencerTJMontanoCBBiedermanJAttention-deficit/hyperactivity disorder in adults: a survey of current practice in psychiatry and primary careArch Intern Med2004164111221122615197048
   PubMedGoogle Scholar
• FaraoneSVBiedermanJMickEThe age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studiesPsychol Med20063615916516420712
   PubMed Web of Science ®Google Scholar
• KesslerRCAdlerLBarkleyRThe prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey replicationAm J Psychiatry200616371672316585449
   PubMed Web of Science ®Google Scholar
• SankaranarayananJPuumalaSEKratochvilCJDiagnosis and treatment of adult attention-deficit/hyperactivity disorder at US ambulatory care visits from 1996 to 2003Curr Med Res Opin20062281475149116870073
   PubMed Web of Science ®Google Scholar
• BarkleyRABrownTEUnrecognized attention-deficit/hyperactivity disorder in adults presenting with other psychiatric disordersCNS Spectr20081397798419037178
   PubMed Web of Science ®Google Scholar
• SearightHRBurkeJMRottnekFAdult ADHD: evaluation and treatment in family medicineAm Fam Physician2000622077208611087189
   PubMed Web of Science ®Google Scholar
• McGoughJJBarkleyRADiagnostic controversies in adult attention deficit hyperactivity disorderAm J Psychiatry20041611948195615514392
   PubMed Web of Science ®Google Scholar
• RiccioCAWolfeMDavisBRomineCGeorgeCLeeDAttention deficit hyperactivity disorder: manifestation in adulthoodArch Clin Neuropsychol20052024926915708734
   PubMed Web of Science ®Google Scholar
• MickEFaraoneSVBiedermanJAge-dependent expression of attention-deficit/hyperactivity disorder symptomsPsychiatr Clin N Am200427215224
   PubMed Web of Science ®Google Scholar
• MannuzzaSKleinRGKleinDFBesslerAShroutPAccuracy of adult recall of childhood attention deficit hyperactivity disorderAm J Psychiatr20021591882188812411223
   PubMed Web of Science ®Google Scholar
• Roy-ByrnePScheeleLBrinkleyJAdult attention-deficit hyperactivity disorder: assessment guidelines based on clinical presentation to a specialty clinicCompr Psychiatry19973831331409154368
   PubMed Web of Science ®Google Scholar
• ApplegateBLaheyBBHartELValidity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trialsJ Am Acad Child Adolesc Psychiatry1997369121112219291722
   PubMed Web of Science ®Google Scholar
• WardMFWenderPHReimherrFWThe Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorderAm J Psychiatry19931508858908494063
   PubMed Web of Science ®Google Scholar
• WilensTEKwonATanguaySCharacteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidityAm J Addict20051431932716188712
   PubMed Web of Science ®Google Scholar
• KolarDKellerAGolfinopoulosMCumynLSyerCHechtmanLTreatment of adults with attention-deficit/hyperactivity disorderNeuropsychiatr Dis Treat20084238940318728745
   PubMedGoogle Scholar
• BiedermanJFaraoneSVSpencerTJMickEMonuteauxMCAleardiMFunctional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the communityJ Clin Psychiatry20066752454016669717
   PubMed Web of Science ®Google Scholar
• BarkleyRAGuevremontDCAnastopoulosADDuPaulGJSheltonTLDriving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: a 3- to 5-year follow-up surveyPediatrics19939222122188337019
   PubMed Web of Science ®Google Scholar
• WilensTEBiedermanJMickEFaraoneSVSpencerTAttention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disordersJ Nerv Ment Dis199718584754829284860
   PubMed Web of Science ®Google Scholar
• BiedermanJWilensTMickEMilbergerSSpencerTJFaraoneSVPsychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidityAm J Psychiatry199515211165216587485630
   PubMed Web of Science ®Google Scholar
• KesslerRCAdlerLAmesMThe World Health Organization adult ADHD self-rep ort scale (ASRS): a short screening scale for use in the general populationPsychol Med20053524525615841682
   PubMed Web of Science ®Google Scholar
• GallagherRBladerJThe diagnosis and neuropsychological assessment of adult attention deficit/hyperactivity disorder: scientific and practical guidelinesAnn NY Acad Sci200193114817111462739
   PubMed Web of Science ®Google Scholar
• AshersonPClinical assessment and treatment of attention deficit hyperactivity disorder in adultsExpert Rev Neurotherapeutics200554525539
   PubMedGoogle Scholar
• WassersteinJDiagnostic issues for adolescents and adults with ADHDJ Clin Psychol20056153554715723419
   PubMed Web of Science ®Google Scholar
• FaraoneSVPerlisRHDoyleAEMolecular genetics of attention-deficit/hyperactivity disorderBiol Psychiatry200557111313132315950004
   PubMed Web of Science ®Google Scholar
• AdlerLSpencerTFaraoneSVValidity of pilot Adult ADHD Self-Report Scale (ASRS) to rate adult ADHD symptomsAnn Clin Psychiatry200618314514816923651
   PubMedGoogle Scholar
• NuttDJFoneKAshersonPEvidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for PsychopharmacologyJ Psychopharmacol2007211104117092962
   PubMed Web of Science ®Google Scholar
• StocklKMHughesTEJarrarMASecnikKPerwienARPhysician perceptions of the use of medications for attention deficit hyperactivity disorderJ Manag Care Pharm20039541642314613439
   PubMedGoogle Scholar
• SafrenSACognitive-behavioral approaches to ADHD treatment in adulthoodJ Clin Psychiatry200667Suppl 8465016961430
   PubMed Web of Science ®Google Scholar
• RostainALRamsayJRA combined treatment approach for adults with ADHD – results of an open study of 43 patientsJ Att Dis2006102150159
   PubMedGoogle Scholar
• PliszkaSAACAP Work Group on Quality IssuesPractice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry200746789492117581453
   PubMed Web of Science ®Google Scholar
• GreenhillLLPliszkaSDulcanMKAmerican Academy of Child and Adolescent Psychiatry. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adultsJ Am Acad Child Adolesc Psychiatry2001412 Suppl26S49S11833633
   PubMed Web of Science ®Google Scholar
• WilensTEFaraoneSVBiedermanJGunawardeneSDoes stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literaturePediatrics2003111117918512509574
   PubMed Web of Science ®Google Scholar
• CoxDJMerkelRLMooreMThorndikeFMullerCKovatchevBRelative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorderPediatrics20061183e704e71016950962
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration: Alert for healthcare professionals: Pemoline tablets and chewable tablets (marketed as Cylert). Food and Drug Administration Web site. Available from: www.fda.gov/cder/drug/InfoSheets/HCP/pemolineHCP.htm Accessed June 16, 2009.
   Google Scholar
• SpencerTBiedermanJWilensTEfficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorderArch Gen Psychiatry200158877578211483144
   PubMed Web of Science ®Google Scholar
• SpencerTBiedermanJWilensTA large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorderBiol Psychiatry200557545646315737659
   PubMed Web of Science ®Google Scholar
• WeislerRHBiedermanJSpencerTJMixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trialCNS Spectr200611862563916871129
   PubMed Web of Science ®Google Scholar
• SpencerTWilensTBiedermanFaraoneSAblonSLapeyKA double – blind, crossover comparison of methylphenidate and placebo in adults with childhood onset attention – deficit hyperactivity disorderArch Gen Psychiatry1995524344437771913
   PubMed Web of Science ®Google Scholar
• AdlerLAGoodmanDWKollinsSHDouble-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorderJ Clin Psychiatry20086991364137319012818
   PubMed Web of Science ®Google Scholar
• MichelsonDAdlerLSpencerTAtomoxetine in adults with ADHD: two randomized, placebo-controlled studiesBiol Psychiatry200353211212012547466
   PubMed Web of Science ®Google Scholar
• AdlerLASpencerTJWilliamsDWMooreRJMichelsonDLong-term, open-label safety and efficacy of atomoxetine in adults with ADHD:final report of a 4-year studyJ Atten Disord200812324825318448861
   PubMed Web of Science ®Google Scholar
• Van BruntDLJohnstonJAYeWFactors associated with initiation with atomoxetine versus stimulants in the treatment of adults with ADHD: retrospective analysis of administrative claims dataJ Manag Care Pharm200612323023816623607
   PubMed Web of Science ®Google Scholar
• WilensTESpencerTJBiedermanJA review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorderJ Atten Disord20025418920211967475
   PubMedGoogle Scholar
• HigginsESJ A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorderJ Fam Pract199948115209934377
   PubMed Web of Science ®Google Scholar
• VerbeeckWTuinierSBekkeringGEAntidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic reviewAdv Ther200926217018419238340
   PubMed Web of Science ®Google Scholar
• ConnorDFFletcherKESwansonJMA meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorderJ Am Acad Child Adolesc Psychiatry199938121551155910596256
   PubMed Web of Science ®Google Scholar
• LindsaySEGudelskyGAHeatonPCUse of modafinil for the treatment of attention deficit/hyperactivity disorderAnn Pharmacother200640101829183316954326
   PubMed Web of Science ®Google Scholar
• EliaJBorcherdingBGPotterWZMeffordINRapoportJLKeysorCSStimulant drug treatment of hyperactivity: biochemical correlatesClin Pharmacol Ther199048157662196146
   PubMed Web of Science ®Google Scholar
• KrauseJSPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorderExpert Rev Neurother20088461162518416663
   PubMedGoogle Scholar
• KrauseKHDreselSHKrauseJKungHFTatschKIncreased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomographyNeurosci Lett2000285210711010793238
   PubMed Web of Science ®Google Scholar
• FaraoneSVSpencerTAleardiMPaganoCBiedermanJMeta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorderJ Clin Psychopharmacol2004241242914709943
   PubMed Web of Science ®Google Scholar
• LuttonMELeachLTriezenbergDClinical inquiries. Does stimulant therapy help adult ADHD?J Fam Pract2003521188888989214599383
   PubMed Web of Science ®Google Scholar
• MedoriRRamos-QuirogaJACasasMKooijJJA randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorderBiol Psychiatry2008631098198918206857
   PubMed Web of Science ®Google Scholar
• JainUHechtmanLWeissMEfficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind placebo-controlled crossover studyJ Clin Psychiatry200768226827717335326
   PubMed Web of Science ®Google Scholar
• ReimherrFWWilliamsEDStrongREMestasRSoniPMarchantBKA double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorderJ Clin Psychiatry20076819310117284136
   PubMed Web of Science ®Google Scholar
• BiedermanJMickESurmanCA randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorderBiol Psychiatry200659982983516373066
   PubMed Web of Science ®Google Scholar
• BiedermanJMickEOSurmanCComparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorderBMC Pschiatry20074749
   Web of Science ®Google Scholar
• FalluARichardCPrinzoRBinderCDoes OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorderCurr Med Res Opin200622122557256617166338
   PubMed Web of Science ®Google Scholar
• RöslerMFischerRAmmerROseCRetzWA randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorderEur Arch Psychiatry Clin Neurosci2009259212012919165529
   PubMed Web of Science ®Google Scholar
• ReinhardtMCBenettiLVictorMMGrevetEHIs age-at-onset criterion relevant for the response to methylphenidate in attention-deficit/hyperactivity disorder?J Clin Psychiatry20076871109111617685750
   PubMed Web of Science ®Google Scholar
• GormanEBKlormanRThatcherJEBorgstedtADEffects of methyl-phenidate on subtypes of attention-deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry200645780881616832317
   PubMed Web of Science ®Google Scholar
• BiedermanJMonuteauxMCSpencerTWilensTEMacphersonHAFaraoneSVStimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up studyAm J Psychiatry2008165559760318316421
   PubMed Web of Science ®Google Scholar
• LevinFREvansSMBrooksDJGarawiFTreatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placeboDrug Alcohol Depend2007871202916930863
   PubMed Web of Science ®Google Scholar
• PetersonKMcDonaghMSFuRComparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysisPsychopharmacology (Berl)2008197111118026719
   PubMed Web of Science ®Google Scholar
• KupermanSPerryPJGaffneyGRBupropion SR vs methylphenidate vs placebo for attention deficit hyperactivity disorder in adultsAnn Clin Psychiatry200113312913411791949
   PubMedGoogle Scholar
• LevinFREvansSMBrooksDJKalbagASGarawiFNunesEVTreatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placeboDrug Alcohol Depend200681213714816102908
   PubMed Web of Science ®Google Scholar
• PalumboDRSalleeFRPelhamWEJrBuksteinOGDavissWBMcDermottMPClonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomesJ Am Acad Child Adolesc Psychiatry200847218021818182963
   PubMed Web of Science ®Google Scholar
• LowKGendaszekAEIllicit use of psychostimulants among college students: a preliminary studyPsychol Health Med20027283287
   Google Scholar
• WeislerRHBiedermanJSpencerTJWilensTELong-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHDCNS Spectr20051012 Suppl 20354316344839
   PubMed Web of Science ®Google Scholar
• WilensTEHammernessPGBiedermanJBlood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorderJ Clin Psychiatry200566225325915705013
   PubMed Web of Science ®Google Scholar
• VetterVLEliaJEricksonCCardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular NursingCirculation2008117182407242318427125
   PubMed Web of Science ®Google Scholar
• Center for Drug Evaluation and ResearchFood and Drug Administration Web site. Available from: www.accessdata.fda.gov/scripts/cder/drugsatfda Accessed June 16, 2009.
   Google Scholar
• BriggsGGFremanRKYaffeSJDrugs in Pregnancy and Lactation7th editionLippincottWilliams & Wilkins200510561057
   Google Scholar
• GolubMCostaLCroftonKNTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of methyl-phenidateBirth Defects Res B Dev Reprod Toxicol200574430038116127684
   PubMedGoogle Scholar
• EinarsonAAbrupt discontinuation of psychotropic drugs following confirmation of pregnancy: a risky practiceJ Obstet Gynaecol Can200527111019102216529668
   PubMedGoogle Scholar
• KingSGriffinSHodgesZA systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescentsHealth Technol Assess20061023iiiivxiii146
   PubMed Web of Science ®Google Scholar
• MarchettiAMagarRLauHPharmacotherapies for attention-deficit/hyperactivity disorder: expected-cost analysisClin Ther200123111904192111768842
   PubMed Web of Science ®Google Scholar
• WuEQBirnbaumHGZhangHFIvanovaJIYangEMalletDHealth care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapiesJ Manag Care Pharm200713756156917874862
   PubMed Web of Science ®Google Scholar